Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leishmaniasis: Current Status of Vaccine Development

1 Sept 2004

Abstract excerpt

Leishmaniasis, a spectrum of diseases caused by various forms of Leishmania has become a major health problem all over the world. Vaccination against leishmaniasis has passed through many developmental stages beginning with the ancient practice of 'leishmanization'. Due to various problems and difficulties associated with traditional vaccines, the interest has been shifted to novel approaches of vaccination like...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 15357215
DOI: 10.2174/1566524043360203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leishmaniasis: Current Status of Vaccine DevelopmentPMID 15357215Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasiteSemantic proximity Read ↗

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read ↗

Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico studySemantic proximity Read ↗

Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani.Semantic proximity Read ↗

Immunogenicity Evaluation of a Novel Lentiviral Vaccine Expressing Multi- Epitope Against of Leishmania Major in BALB/c MiceSemantic proximity Read ↗

Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasisSemantic proximity Read ↗

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral LeishmaniasisSemantic proximity Read ↗

Post-Genomics and Vaccine Improvement for LeishmaniaSemantic proximity Read ↗

Immunotherapeutic Potential of the Recombinant <em>Leishmania infantum</em> Eukaryotic Initiation Factor (LieIF) in Murine Experimental Models of LeishmaniasisSemantic proximity Read ↗

Investigation of Leish-111f Epitopes to Design a New Multi-epitope Vaccine Against Leishmania Major Using Immunoinformatics ApproachesSemantic proximity Read ↗

Live attenuated Leishmania vaccines: a potential strategic alternativeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.